Niche Investment Focus Empery Asset Management specializes in event-driven investments in small-cap public companies under one billion dollars, indicating a targeted approach that may benefit from tailored financial technology solutions and analyst tools.

Recent Asset Acquisition The company recently invested approximately 1.1 million dollars in Sunshine Biopharma, showcasing active engagement in biotech sectors, which presents opportunities for pharmaceutical and biotech-related service providers or investment platforms.

Modest Revenue Range With annual revenues estimated between 1 and 10 million dollars, Empery presents an opportunity for financial service providers offering cost-effective solutions tailored for smaller asset managers.

Limited Workforce Operating with a small team of under 10 employees, Empery may prioritize streamlined, easy-to-implement tools, making cloud-based software, automation services, or outsourced solutions particularly attractive.

Strategic Location Based in midtown Manhattan, Empery is well-positioned for networking and partnerships with other financial firms in New York, expanding potential business development opportunities in a major financial hub.